Skip to content
Home/Companies/MedTech/Triomed

Triomed

MedTech·Sweden·Active·14yr hold
Entry
2012
Hold
14yr
Status
Active

Who owns Triomed?

Triomed is a Swedish MedTech company, currently owned by Almi Invest since 2012.

Hand-verified · updated 2026-08-18

Open JSON · CC-BY
Almi Invest
Investor
Almi Invest
Almi Invest (Regional funds) · 2009 · VC

Key facts

HQSweden
SectorMedTech
StatusActive

More from Almi Invest (Regional funds)

Other portfolio companies in the same fund.

Cellevate
Active
BiotechSweden· 2026
CubaseBio
Active
BiotechSweden· 2026
DAJE Prevent
Active
MedTechSweden· 2026
Permitify
Active
SaaSSweden· 2026
Radar Reticence
Active
SoftwareSweden· 2026
Rivus
Active
SoftwareSweden· 2026

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Triomed?

Triomed is currently owned by Almi Invest, through Almi Invest (Regional funds), since 2012.

When did Almi Invest acquire Triomed?

Almi Invest acquired Triomed in 2012.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue